Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary Anastomosis

NCT03404258 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03404258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03404258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary Anastomosis
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Active, not recruiting
Start date
February 10, 2018
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelin, metabolomics, pulmonary vascular resistance abnormality, single-ventricle, superior cavo-pulmonary anastomosis